Oppenheimer & Co. Inc. lowered its position in shares of Oracle Corporation (NYSE:ORCL - Free Report) by 8.5% during the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 70,226 shares of the enterprise software provider's stock after selling 6,537 shares during the quarter. Oppenheimer & Co. Inc.'s holdings in Oracle were worth $9,818,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also recently bought and sold shares of the company. Norges Bank bought a new position in shares of Oracle during the fourth quarter valued at approximately $2,216,314,000. Raymond James Financial Inc. bought a new position in shares of Oracle during the fourth quarter valued at approximately $930,095,000. GAMMA Investing LLC grew its holdings in shares of Oracle by 15,012.3% during the first quarter. GAMMA Investing LLC now owns 4,755,096 shares of the enterprise software provider's stock valued at $664,810,000 after purchasing an additional 4,723,631 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its holdings in shares of Oracle by 20.5% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 13,825,360 shares of the enterprise software provider's stock valued at $2,303,858,000 after purchasing an additional 2,350,448 shares during the last quarter. Finally, Vanguard Group Inc. grew its holdings in shares of Oracle by 1.5% during the fourth quarter. Vanguard Group Inc. now owns 157,411,949 shares of the enterprise software provider's stock valued at $26,231,127,000 after purchasing an additional 2,296,069 shares during the last quarter. Institutional investors and hedge funds own 42.44% of the company's stock.
Oracle Price Performance
Shares of NYSE:ORCL opened at $207.08 on Tuesday. Oracle Corporation has a one year low of $118.86 and a one year high of $216.60. The stock has a fifty day moving average of $161.85 and a 200-day moving average of $161.26. The company has a market capitalization of $581.65 billion, a PE ratio of 47.71, a price-to-earnings-growth ratio of 3.08 and a beta of 1.32. The company has a debt-to-equity ratio of 4.07, a quick ratio of 0.75 and a current ratio of 0.75.
Oracle (NYSE:ORCL - Get Free Report) last announced its quarterly earnings data on Wednesday, June 11th. The enterprise software provider reported $1.70 EPS for the quarter, beating analysts' consensus estimates of $1.64 by $0.06. Oracle had a return on equity of 87.34% and a net margin of 21.68%. The company had revenue of $15.90 billion during the quarter, compared to the consensus estimate of $15.58 billion. During the same quarter in the prior year, the firm earned $1.63 EPS. The company's quarterly revenue was up 11.3% compared to the same quarter last year. As a group, equities analysts anticipate that Oracle Corporation will post 5 EPS for the current fiscal year.
Oracle Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Thursday, July 24th. Stockholders of record on Thursday, July 10th will be issued a $0.50 dividend. The ex-dividend date is Thursday, July 10th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.97%. Oracle's payout ratio is currently 46.08%.
Insider Activity
In other news, Director Naomi O. Seligman sold 2,000 shares of the stock in a transaction on Wednesday, April 2nd. The stock was sold at an average price of $145.81, for a total value of $291,620.00. Following the completion of the sale, the director now owns 34,630 shares in the company, valued at $5,049,400.30. This represents a 5.46% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Clayton M. Magouyrk sold 15,000 shares of the stock in a transaction on Tuesday, June 17th. The stock was sold at an average price of $214.10, for a total value of $3,211,500.00. Following the sale, the insider now owns 60,722 shares of the company's stock, valued at approximately $13,000,580.20. This represents a 19.81% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 442,366 shares of company stock worth $83,395,223 over the last quarter. Corporate insiders own 42.20% of the company's stock.
Wall Street Analyst Weigh In
Several equities analysts have recently commented on the company. Evercore ISI reaffirmed a "buy" rating on shares of Oracle in a report on Wednesday, June 18th. Citigroup reissued an "outperform" rating on shares of Oracle in a report on Thursday, June 12th. UBS Group reissued a "buy" rating and issued a $225.00 price objective (up from $200.00) on shares of Oracle in a report on Thursday, June 12th. Mizuho decreased their price objective on Oracle from $210.00 to $180.00 and set an "outperform" rating for the company in a report on Tuesday, April 15th. Finally, KeyCorp increased their price objective on Oracle from $200.00 to $225.00 and gave the stock an "overweight" rating in a report on Thursday, June 12th. Eleven research analysts have rated the stock with a hold rating, twenty-one have issued a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat, Oracle currently has a consensus rating of "Moderate Buy" and an average price target of $196.74.
View Our Latest Report on ORCL
Oracle Profile
(
Free Report)
Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.
Featured Articles
Want to see what other hedge funds are holding ORCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oracle Corporation (NYSE:ORCL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Oracle, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oracle wasn't on the list.
While Oracle currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report